Judith Absalon

22.7k total citations
37 papers, 892 citations indexed

About

Judith Absalon is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Judith Absalon has authored 37 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 16 papers in Microbiology and 11 papers in Infectious Diseases. Recurrent topics in Judith Absalon's work include Pneumonia and Respiratory Infections (17 papers), Bacterial Infections and Vaccines (14 papers) and HIV/AIDS Research and Interventions (8 papers). Judith Absalon is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Bacterial Infections and Vaccines (14 papers) and HIV/AIDS Research and Interventions (8 papers). Judith Absalon collaborates with scholars based in United States, United Kingdom and Denmark. Judith Absalon's co-authors include Avis J. Thomas, Rong Yang, John L. Perez, Kathrin U. Jansen, Annaliesa S. Anderson, Shannon L. Harris, Laura J. York, Thomas R. Jones, Marco Mancini and Donnie McGrath and has published in prestigious journals such as New England Journal of Medicine, The Lancet and American Journal of Clinical Nutrition.

In The Last Decade

Judith Absalon

36 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Absalon United States	17	466	412	308	209	157	37	892
Wanatpreeya Phongsamart Thailand	15	316 0.7×	414 1.0×	106 0.3×	132 0.6×	124 0.8×	75	708
Claire von Mollendorf United States	19	735 1.6×	407 1.0×	212 0.7×	97 0.5×	42 0.3×	61	1.1k
Sonia Stoszek United States	18	820 1.8×	389 0.9×	180 0.6×	45 0.2×	79 0.5×	39	1.3k
Per Björkman Sweden	24	1.0k 2.2×	881 2.1×	162 0.5×	454 2.2×	90 0.6×	92	1.7k
Fiona V Cresswell United Kingdom	22	564 1.2×	701 1.7×	312 1.0×	83 0.4×	91 0.6×	65	1.2k
Andrea Kovacs United States	18	385 0.8×	396 1.0×	72 0.2×	220 1.1×	100 0.6×	28	776
Anne Coletti United States	13	262 0.6×	520 1.3×	220 0.7×	175 0.8×	27 0.2×	20	758
Nyaradzo Mgodi United States	17	425 0.9×	706 1.7×	123 0.4×	173 0.8×	69 0.4×	61	993
Esaú João Brazil	16	238 0.5×	540 1.3×	63 0.2×	189 0.9×	174 1.1×	56	736
Tendesayi Kufa South Africa	16	285 0.6×	455 1.1×	164 0.5×	117 0.6×	38 0.2×	71	698

Countries citing papers authored by Judith Absalon

Since Specialization

Citations

This map shows the geographic impact of Judith Absalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Absalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Absalon more than expected).

Fields of papers citing papers by Judith Absalon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Absalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Absalon. The network helps show where Judith Absalon may publish in the future.

Co-authorship network of co-authors of Judith Absalon

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Absalon. A scholar is included among the top collaborators of Judith Absalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Absalon. Judith Absalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Jonathan, Kimberly Workowski, Stephanie N. Taylor, et al.. (2025). Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. The Lancet. 405(10489). 1608–1620. 11 indexed citations

Cutland, Clare, Shobna Sawry, Lee Fairlie, et al.. (2024). Obstetric and neonatal outcomes in South Africa. Vaccine. 42(6). 1352–1362. 1 indexed citations

Momplaisir, Florence, Shirley Delair, Mona Rigaud, et al.. (2024). Ending Race-Conscious College Admissions and Its Potential Impact on the Infectious Disease Workforce. Open Forum Infectious Diseases. 11(3). ofae083–ofae083.

Beeslaar, Johannes, Susan Mather, Judith Absalon, et al.. (2022). Safety data from the MenB-FHbp clinical development program in healthy individuals aged 10 years and older. Vaccine. 40(12). 1872–1878. 2 indexed citations

Østergaard, Lars, Timo Vesikari, Shelly Senders, et al.. (2021). Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months. Vaccine. 39(32). 4545–4554. 7 indexed citations

Beeslaar, Johannes, Judith Absalon, Annaliesa S. Anderson, et al.. (2020). MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious Diseases and Therapy. 9(3). 641–656. 4 indexed citations

Eckert, Linda O., Christine E. Jones, Alisa Kachikis, et al.. (2020). Obstetrics risk Assessment: Evaluation of selection criteria for vaccine research studies in pregnant women. Vaccine. 38(29). 4542–4547. 1 indexed citations

Beeslaar, Johannes, Paula Peyrani, Judith Absalon, et al.. (2020). Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data. Infectious Diseases and Therapy. 9(3). 625–639. 3 indexed citations

Absalon, Judith, Nathan Segall, Stan L. Block, et al.. (2020). Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial. The Lancet Infectious Diseases. 21(2). 263–274. 89 indexed citations

10.

Harris, Shannon L., Cuiwen Tan, Lubomira Andrew, et al.. (2018). The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci. Vaccine. 36(45). 6867–6874. 27 indexed citations

11.

Beeslaar, Johannes, Judith Absalon, Paul Balmer, et al.. (2018). Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adults. Vaccine. 36(28). 4004–4013. 6 indexed citations

12.

Iadeluca, Laura, et al.. (2017). Maternal Screening And Treatment For Group B Streptococcus (GBS) Are Associated With Non-Adherence To Guidelines, False-Negative Results And High Management Costs In The United Kingdom, Italy, France, Spain And Germany. Value in Health. 20(9). A797–A798. 2 indexed citations

13.

Østergaard, Lars, Gregg Lucksinger, Judith Absalon, et al.. (2016). A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults. Vaccine. 34(12). 1465–1471. 19 indexed citations

14.

Senders, Shelly, Prakash Bhuyan, Qin Jiang, et al.. (2016). Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine. The Pediatric Infectious Disease Journal. 35(5). 548–554. 34 indexed citations

15.

Giordano, Thomas P., Glenn E. Bartsch, Yafeng Zhang, et al.. (2010). Disparities in Outcomes for African American and Latino Subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) Trial. AIDS Patient Care and STDs. 24(5). 287–295. 33 indexed citations

16.

Molina, Jean‐Michel, Jaime Andrade‐Villanueva, Juan Echevarría, et al.. (2010). Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(3). 323–332. 183 indexed citations

17.

Squires, K., et al.. (2010). Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. Journal of Antimicrobial Chemotherapy. 66(2). 363–370. 30 indexed citations

18.

Tedaldi, Ellen, Judith Absalon, Avis J. Thomas, Judith C. Shlay, & Mary van den Berg-Wolf. (2008). Ethnicity, Race, and Gender. JAIDS Journal of Acquired Immune Deficiency Syndromes. 47(4). 441–448. 45 indexed citations

19.

Wilson, Tracey E., David Vlahov, Stephen Crystal, et al.. (2006). Integrating HIV Prevention Activities into the HIV Medical Care Setting: A Report from the NYC HIV Centers Consortium. Journal of Urban Health. 83(1). 18–30. 3 indexed citations

20.

Muntzel, Martin S., Daniel C. Hatton, Judith Absalon, & David A. McCarron. (1988). Dietary calcium and iron interaction on hematocrit in the shr. Kidney International. 33(1). 302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact